Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 24, 2014
- Accepted in final form January 20, 2015
- First Published April 2, 2015.
Author Disclosures
- Sudarshini Ramanathan, FRACP,
- Daman Langguth, FRACP, FRCPA,
- Todd A. Hardy, FRACP, PhD,
- Nidhi Garg, MBBS,
- Chris Bundell, PhD,
- Arada Rojana-Udomsart, PhD,
- Russell C. Dale, PhD,
- Thomas Robertson, FRCPA,
- Andrew L. Mammen, MD, PhD and
- Stephen W. Reddel, FRACP, PhD
- Sudarshini Ramanathan, FRACP,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Sudarshini Ramanathan has received a scholarship from the National Health and Medical Research Council (Australia)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daman Langguth, FRACP, FRCPA,
Tocilizumab in asthma phase 1 trial, university of Queensland, not for profit.
NONE
Speakers fees for Roche on off label use of rituximab
NONE
NONE
NONE
Sullivan Nicolaides Pathology, director of immunology, 8 years
NONE
NONE
NONE
NONE
NONE
NHMRC development grant for Grass allergy research (Pas n 1 sIgE test)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Todd A. Hardy, FRACP, PhD,
NONE
NONE
NONE
Advances in Clinical Neuroscience, Associate Editor, 2013-2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nidhi Garg, MBBS,
NONE
NONE
NONE
NONE
NONE
NONE
Current position as Neuromuscular Fellow at Concord Hospital is partly funded by the drug company, Allergan.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chris Bundell, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Arada Rojana-Udomsart, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Russell C. Dale, PhD,
Queensland Children's Medical Institute Research advisory committee. Not for profit.
NONE
received an honoraria for lecturing from Biogen Idec
Editorial advisory board member of MSARD Editorial board member of Neurology: Neuroimmunology and Neuroinflammation Editorial board member of European Journal of Paediatric Neurology
NONE
Biogen Idec 1000 dollar honoria in 2008
NONE
NONE
NONE
NONE
NONE
NONE
NHMRC national grant in 2011 national grant for encephalitis study NHMRC practitioner fellowship 2014-8 NHMRC project grant 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Robertson, FRCPA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andrew L. Mammen, MD, PhD and
aTYR pharmaceuticals advisory board Biogen advisory board
NONE
NONE
Experimental Neurology, Editorial Board, 2013-Arthritis and Rheumatism, Editorial Board, 2014-
Patented test for anti-HMGCR antibodies that is licensed to INOVA diagnostics
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH, K08
NONE
NONE
NONE
Licensed test for anti-HMGCR antibodies to INOVA Diagnostics
Licensed test for anti-HMGCR antibodies to INOVA Diagnostics
NONE
NONE
NONE
- Stephen W. Reddel, FRACP, PhD
1. CSL 2. Baxter 3. Genzyme 4. Biogen 5. National Immunoglobulin Governmental Advisory Council, Australia
NONE
1. CSL 2. Genzyme 3. Biogen
NONE
NONE
NONE
NSW Health, Australia
NONE
NONE
NONE
NONE
1. Genzyme
NONE
NONE
Beeren Foundation
1. Sydney Neurology 2. Medical Safety Systems
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (S.R., T.A.H., N.G., S.W.R.), Concord Repatriation General Hospital, Sydney, New South Wales, Australia; Neuroimmunology Group (S.R., R.C.D.), Institute for Neuroscience and Muscle Research, The Kids Research Institute at the Children's Hospital at Westmead, Sydney Medical School, University of Sydney, New South Wales, Australia; Department of Neurology (S.R.), Westmead Hospital, Sydney, New South Wales, Australia; Sullivan Nicolaides Pathology (D.L.), Brisbane, Queensland, Australia; Concord Clinical School (T.A.H., S.W.R.), University of Sydney, New South Wales, Australia; Clinical Immunology (C.B.), PathWest, QEII Medical Center, Nedlands, Western Australia, Australia; School of Pathology and Laboratory Medicine (C.B.), University of Western Australia, Nedlands, Western Australia, Australia; Australian Neuro-Muscular Research Institute (ANRI) and Centre for Neuromuscular and Neurological Disorders (CNND) (A.R.-U.), University of Western Australia, QEII Medical Centre, Nedlands, Western Australia, Australia; Pathology Queensland (T.R.), Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia; and National Institute of Arthritis and Musculoskeletal and Skin Diseases (A.L.M.), National Institutes of Health, Bethesda, MD.
- Correspondence to Dr. Reddel: swreddel{at}sydneyneurology.com.au
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Alert Me
Recommended articles
-
Article
Inflammatory myopathy with myasthenia gravisThymoma association and polymyositis pathologyNaohiro Uchio, Kenichiro Taira, Chiseko Ikenaga et al.Neurology: Neuroimmunology & Neuroinflammation, December 24, 2018 -
Article
Cancer association as a risk factor for anti-HMGCR antibody-positive myopathyMasato Kadoya, Ayumi Hida, Meiko Hashimoto Maeda et al.Neurology: Neuroimmunology & Neuroinflammation, October 07, 2016 -
Article
Overlapping features of polymyositis and inclusion body myositis in HIV-infected patientsThomas E. Lloyd, Iago Pinal-Fernandez, E. Harlan Michelle et al.Neurology, March 10, 2017 -
Article
High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathiesChristopher A. Mecoli, Arash H. Lahouti, Robert A. Brodsky et al.Neurology: Neuroimmunology & Neuroinflammation, July 11, 2017